Sharechat Logo

TradeWindow Issues Share Options to Independent Directors

Thursday 15th September 2022

Text too small?

Auckland, NZ. TradeWindow (NZX: TWL ) is issuing 300,000 options (Options) to the three Independent Directors of TradeWindow, being Alasdair MacLeod, Diana Puketapu and Philip Norman, as approved by resolution at the Annual General Meeting of Shareholders held online on 14 September 2022. The issue of the Options is to occur today (15 September 2022).

Each Option will, upon vesting and exercise of the Option, entitle the holder to one ordinary share in the Company. The Options will be issued today (15 September 2022) but with an effective date of 14 September 2022 (Effective Date), with a nil exercise price and will vest in the following tranches:

• 2/3 of options vest on 30 September 2023

• 1/3 of options vest on 30 September 2024

The issue price for the Options is the VWAP of TradeWindow Shares over the 20 Business Day period prior to the Effective Date, subject to a floor price of NZ$0.70 per share.

TradeWindow considers that issuing the Options to the Independent Directors will assist in aligning incentives with those of the shareholders of TradeWindow and in encouraging those directors to pursue long term value creation for the Company.

Following the issue of the Options the total number of shares, live options, and deferred share rights is:

Ordinary Shares: 100,804,700

Options: 1,537,238

ENDS

Capital Change Notice



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

RAK - 1H26: Strong first half growth and strategic momentum
Green Cross Health Interim Results to 30 September 2025
Devon Funds Morning Note - 28 November 2025
November 28th Morning Report
Pacific Edge Appoints Chief Commercial Officer
Ryman Healthcare reports 1H26 results
Tower reports record FY25 result, increased dividends
NZ King Salmon Investments Ltd releases FY25 (Sept) results
RBNZ - OCR lowered to 2.25%
SVR - Savor Interim Results and Trading Update